drug_name,side_effect,side_effect_1,side_effect_2,side_effect_3,side_effect_4,disease_name,clinical_trial_institution
cetuximab,somnolence,headache,cough,renal failure,carcinoma,Adenocarcinoma,Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,Complementary component deficiency,Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"IgG receptor I, phagocytic, familial deficiency of",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,Lupus erythematosus,Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,Lymphoma,Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,Neutropenia,Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,Nonsmall cell lung cancer,Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,Viral infection,Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"C1q deficiency, type A",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"C1q deficiency, type B",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"C1s deficiency, isolated",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"Lupus nephritis, susceptibility to",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"Lymphoma, progression of",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"Neutropenia, alloimmune neonatal",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980",Medical University of Vienna
cetuximab,somnolence,headache,cough,renal failure,carcinoma,"Viral infections, recurrent",Medical University of Vienna
denileukin diftitox,dizziness,headache,pain,dehydration,vasodilatation,"Interleukin-2 receptor, alpha chain, deficiency of",Medical University of Vienna
denileukin diftitox,dizziness,headache,pain,dehydration,vasodilatation,Severe combined immunodeficiency,Medical University of Vienna
denileukin diftitox,dizziness,headache,pain,dehydration,vasodilatation,Combined immunodeficiency,Medical University of Vienna
denileukin diftitox,dizziness,headache,pain,dehydration,vasodilatation,"Combined immunodeficiency, X-linked, moderate, 312863",Medical University of Vienna
denileukin diftitox,dizziness,headache,pain,dehydration,vasodilatation,"Severe combined immunodeficiency, X-linked, 300400",Medical University of Vienna
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Asthma,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Asthma,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Complementary component deficiency,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Complementary component deficiency,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Dementia,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Dementia,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"IgG receptor I, phagocytic, familial deficiency of",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"IgG receptor I, phagocytic, familial deficiency of",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Lupus erythematosus,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Lupus erythematosus,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Lymphoma,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Lymphoma,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Malaria,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Malaria,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Migraine,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Migraine,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Myocardial infarction,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Myocardial infarction,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Neutropenia,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Neutropenia,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Sepsis,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Sepsis,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Viral infection,University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,Viral infection,University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Asthma, susceptibility to, 600807",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Asthma, susceptibility to, 600807",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"C1q deficiency, type A",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"C1q deficiency, type A",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"C1q deficiency, type B",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"C1q deficiency, type B",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"C1s deficiency, isolated",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"C1s deficiency, isolated",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Dementia, vascular, susceptibility to",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Dementia, vascular, susceptibility to",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Lupus nephritis, susceptibility to",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Lupus nephritis, susceptibility to",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Lymphoma, progression of",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Lymphoma, progression of",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Malaria, cerebral, susceptibility to",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Malaria, cerebral, susceptibility to",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Migraine without aura, susceptibility to, 157300",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Migraine without aura, susceptibility to, 157300",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Myocardial infarction, susceptibility to",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Myocardial infarction, susceptibility to",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Neutropenia, alloimmune neonatal",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Neutropenia, alloimmune neonatal",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Septic shock, susceptibility to",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Septic shock, susceptibility to",University of Michigan Cancer Center
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Viral infections, recurrent",University of Alabama at Birmingham
etanercept,dizziness,abdominal pain,nausea,melanoma,vasodilatation,"Viral infections, recurrent",University of Michigan Cancer Center
urokinase,back pain,fever,nausea,melanoma,vasodilatation,Alzheimer disease,University of Michigan Cancer Center
urokinase,back pain,fever,nausea,melanoma,vasodilatation,"Conjunctivitis, ligneous",University of Michigan Cancer Center
urokinase,back pain,fever,nausea,melanoma,vasodilatation,Plasminogen deficiency,University of Michigan Cancer Center
urokinase,back pain,fever,nausea,melanoma,vasodilatation,"Alzheimer disease, late-onset, susceptibility to, 104300",University of Michigan Cancer Center
urokinase,back pain,fever,nausea,melanoma,vasodilatation,"Conjunctivitis, ligneous, 217090",University of Michigan Cancer Center
urokinase,back pain,fever,nausea,melanoma,vasodilatation,Plasminogen Tochigi disease,University of Michigan Cancer Center
abciximab,back pain,fever,nausea,melanoma,vasodilatation,Complementary component deficiency,University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,Glanzmann thrombasthenia,University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,"IgG receptor I, phagocytic, familial deficiency of",University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,Lupus erythematosus,University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,Lymphoma,University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,Neutropenia,University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,Viral infection,University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,"C1q deficiency, type A",University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,"C1q deficiency, type B",University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,"C1s deficiency, isolated",University of Pisa
abciximab,back pain,fever,nausea,melanoma,vasodilatation,"Glanzmann thrombasthenia, type B",University of Pisa
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,Asthma,University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,Atherosclerosis,University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,Cortisol resistance,University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,Malaria,University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,Obesity,University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,"Asthma, dimished response to antileukotriene treatment in, 600807",University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,"Atherosclerosis, susceptibility to",University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,"Malaria, resistance to, 248310",University of Versailles
hydrocortisone,back pain,fever,nausea,melanoma,vasodilatation,"Obesity, adrenal insufficiency, and red hair",University of Versailles
